Showing results (381-390 of 632) with videos related to
Sort By:
Pageof 64
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.Clinical Chemistry and Laboratory Medicine|April 6, 2019
Biomarker-assisted identification of sepsis-related acute liver impairment: a frequent and deadly condition in critically ill patientsJens-Ulrik Stæhr Jensen, Lars Peters, Theis S Itenov, et al.AIDS (London, England)|May 26, 2011
Tuberculosis among HIV-positive patients across Europe: changes over time and risk factorsAlexey Kruk, Wendy Bannister, Daria N Podlekareva, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
Nondisplaceable Binding Is a Potential Confounding Factor in 11C-PBR28 Translocator Protein PET StudiesGjertrud L Laurell, Pontus Plavén-Sigray, Aurelija Jucaite, et al.AIDS (London, England)|October 23, 2020
Genome-wide association study of high-sensitivity C-reactive protein, D-dimer, and interleukin-6 levels in multiethnic HIV+ cohortsBrad T Sherman, Xiaojun Hu, Kanal Singh, et al.HIV Medicine|May 20, 2015
Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA studyD Podlekareva, D Grint, I Karpov, et al.HIV Medicine|September 17, 2004
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized studyB T Røge, T S Barfod, O Kirk, et al.Antiviral Therapy|September 6, 2008
Incidence of abacavir hypersensitivity reactions in euroSIDAWendy P Bannister, Nina Friis-Møller, Amanda Mocroft, et al.Journal of Clinical Epidemiology|November 1, 1996
Factors associated with the CD4+ lymphocyte count at diagnosis of acquired immunodeficiency syndrome. The AIDS IN EUROPE Study GroupA N Phillips, A Lazzarin, J Gonzales-Lahoz, et al.Antiviral Therapy|June 27, 2007
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell countsAmanda Mocroft, Schlomo Staszewski, Rainer Weber, et al.Pageof 64